Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid Leukemia

Pharmacokinetics of Venetoclax Co-Administered with Posaconazole in Patients with Acute Myeloid Leukemia

The Food and Drug Administration currently approves the combination of hypomethylating agents (HMA), azacytidine or decitabine with venetoclax (VEN) for acute myeloid leukemia (AML) patients aged more than 75 years and for patients unsuitable for intensive chemotherapy. The risk of fungal infection...

Full description

Saved in:
Bibliographic Details
Main Authors: Simona De Gregori (Author), Eleonora Gelli (Author), Mara Capone (Author), Giulia Gambini (Author), Elisa Roncoroni (Author), Marianna Rossi (Author), Claudia Patricia Tobar Cabrera (Author), Gianluca Martini (Author), Ludovica Calabretta (Author), Luca Arcaini (Author), Riccardo Albertini (Author), Patrizia Zappasodi (Author)
Format: Book
Published: MDPI AG, 2023-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items